Carregant...
Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy
BACKGROUND: Etanercept and other anti-TNF-alpha agents have been indicated as a therapeutic option in severe drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Etanercept has been shown to quickly reduce the detachment of the epidermis and shorten healing time. Cases...
Guardat en:
| Publicat a: | J Dermatol Case Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Specjalisci Dermatolodzy
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844530/ https://ncbi.nlm.nih.gov/pubmed/27119002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2016.1224 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|